2,909
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series

, , , , , , , , , , & show all
Article: 2198050 | Received 26 Mar 2023, Accepted 27 Mar 2023, Published online: 10 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaohua Wang, Liyan Yuan, Xiaoyu Qiu, Bin Yang & Mao-Qiang Man. (2023) Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases. Clinical, Cosmetic and Investigational Dermatology 16, pages 1933-1936.
Read now

Articles from other publishers (6)

Nazila Ghoreishi Amin, Sepehr Khosravi, Najmolsadat Atefi, Farnoosh Seirafianpour, Sahand Farhoodi & Azadeh Goodarzi. (2023) A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting. Immunity, Inflammation and Disease 11:11.
Crossref
Yuting Chen, Yangyang Qiu, Meiqing Chen, Ling Huang, Xinyu Lin, Xiaoyan Qiu, Yi Wei & Lujuan Gao. (2023) Transition from secukinumab to adalimumab in COVID‐19 ‐induced psoriasis flare‐up treatment: A case report . Clinical Case Reports 11:10.
Crossref
Luca Potestio, Teresa Battista, Sara Cacciapuoti, Angelo Ruggiero, Fabrizio Martora, Luigi Fornaro, Elisa Camela & Matteo Megna. (2023) New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge. Biomedicines 11:8, pages 2191.
Crossref
Gabriela Mariana Iancu, Estera Molnar, Loredana Ungureanu, Simona Corina Șenilă, Adrian Hașegan & Maria Rotaru. (2023) SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation. Life 13:7, pages 1576.
Crossref
Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo & Mario Valenti. (2023) A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks. Dermatology Reports.
Crossref
Kelvin Truong & Keng‐Ee Thai. (2023) Cushing's syndrome induced by enhanced systemic absorption of topical corticosteroids when co‐administered with hand sanitiser in a patient with COVID‐19‐induced chronic plaque psoriasis. Skin Research and Technology 29:6.
Crossref